A NOVEL METHOD TO PREDICT THE ELIMINATION HALF-LIVES AND THE RENAL EXCRETION MECHANISMS OF CEPHALOSPORINS
スポンサーリンク
概要
- 論文の詳細を見る
A novel method was proposed to predict the elimination half-lives of cephalosporins from plasma protein binding (unbound fraction, f) and fraction of the dose excreted into urine (f^*) on the basis of the following four assumptions. 1) The drug is only distributed to the extracellular fluid, 2) the bound fraction of the drug in plasma is independent of the plasma drug concentration, 3) the binding protein of the drug is albumin, 4) the unbound drug in plasma is excreted by the glomerular filtration and the contribution of active secretion andreabsorption is negligible. The V_<ss>'s and t_<1/2β>'s of MT-141,one of cephalosporins, in rabbits, dogs and healthy human subjects were well predicted, whereas in rats, the prediction of the both values was failed The t_<1/2β>'s of various cephalosporins in healthy subjects were calculated from f and f^*, in reasonably good agreement with the observed ones, except for some cephalosporins which have been reported to be secreted actively in the renal tubules. Thus, the comparison of the calculated t_<1/2β>'s with the observed ones makes it possible to presume the renal excretion mechanism. Moreover, this method will be applicable to other drugs which satisfy the above four assumptions.
- 公益社団法人日本薬学会の論文
著者
-
Fujita Masataka
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.
-
KOMIYA IZUMI
Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha, Ltd.
-
NISHIO MOTOHIRO
Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha, Ltd.
-
MURATA SHINJIRO
Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha, Ltd.
-
CHIBA FUMIKO
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
SAKURAI TAKASHI
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
SHINKAI SACHIHIKO
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
Komiya Izumi
Pharmacology And Toxicology Laboratories Meiji Seika Kaisha Ltd.
-
Komiya Izumi
Central Research Laboratories Meiji Seika Kaisha Ltd.
-
Murata Shinjiro
Pharmacology And Toxicology Laboratories Meiji Seika Kaisha Ltd.
-
Chiba Fumiko
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.
-
Shinkai Sachihiko
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.
-
Nishio Motohiro
Pharmacology And Toxicology Laboratories Meiji Seika Kaisha Ltd.
-
Sakurai Takashi
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.
関連論文
- A NOVEL METHOD TO PREDICT THE ELIMINATION HALF-LIVES AND THE RENAL EXCRETION MECHANISMS OF CEPHALOSPORINS
- PHARMACOKINETICS OF DIBEKACIN IN RABBITS AND DOGS
- ACUTE TOXICITY AND PHARMACOKINETICS OF DIBEKACIN IN MICE
- MECHANISM OF RENAL DISTRIBUTION OF AMINOGLYCOSIDE ANTIBIOTICS
- URINE FLOW-DEPENDENCE AND INTERSPECIES VARIATION OF THE RENAL REABSORPTION OF SULFANILAMIDE
- MODE OF PROTECTIVE ACTION OF FOSFOMYCIN AGAINST DIBEKACIN-INDUCED NEPHROTOXICITY IN THE DEHYDRATED RATS